Bank of Montreal’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,414
| Closed | -$255 | – | 4424 |
|
|
2022
Q2 | $255 | Sell |
3,414
-913
| -21% | -$68K | ﹤0.01% | 3107 |
|
|
2022
Q1 | $348K | Buy |
4,327
+922
| +27% | +$83.1K | ﹤0.01% | 3101 |
|
|
2021
Q4 | $349K | Sell |
3,405
-624
| -15% | -$62.2K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $372K | Sell |
4,029
-213
| -5% | -$20.5K | ﹤0.01% | 3032 |
|
|
2021
Q2 | $435K | Buy |
4,242
+665
| +19% | +$66.8K | ﹤0.01% | 2896 |
|
|
2021
Q1 | $356K | Sell |
3,577
-65
| -2% | -$5.92K | ﹤0.01% | 2855 |
|
|
2020
Q4 | $291K | Buy |
3,642
+1,868
| +105% | +$144K | ﹤0.01% | 3013 |
|
|
2020
Q3 | $133K | Buy |
1,774
+303
| +21% | +$24.3K | ﹤0.01% | 2933 |
|
|
2020
Q2 | $121K | Buy |
1,471
+1,032
| +235% | +$81K | ﹤0.01% | 3000 |
|
|
2020
Q1 | $27K | Sell |
439
-1,585
| -78% | -$110K | ﹤0.01% | 3136 |
|
|
2019
Q4 | $159K | Buy |
2,024
+497
| +33% | +$36.6K | ﹤0.01% | 3277 |
|
|
2019
Q3 | $104K | Buy |
1,527
+231
| +18% | +$15.5K | ﹤0.01% | 3268 |
|
|
2019
Q2 | $103K | Buy |
1,296
+73
| +6% | +$5.79K | ﹤0.01% | 3319 |
|
|
2019
Q1 | $102K | Sell |
1,223
-257
| -17% | -$26.8K | ﹤0.01% | 3051 |
|
|
2018
Q4 | $175K | Sell |
1,480
-3,656
| -71% | -$423K | ﹤0.01% | 2653 |
|
|
2018
Q3 | $619K | Buy |
5,136
+23
| +0.4% | +$2.85K | ﹤0.01% | 2237 |
|
|
2018
Q2 | $589K | Buy |
5,113
+3,586
| +235% | +$392K | ﹤0.01% | 2252 |
|
|
2018
Q1 | $131K | Buy |
1,527
+480
| +46% | +$37.2K | ﹤0.01% | 2845 |
|
|
2017
Q4 | $77K | Buy |
1,047
+559
| +115% | +$37.4K | ﹤0.01% | 3106 |
|
|
2017
Q3 | $28K | Sell |
488
-130
| -21% | -$7.68K | ﹤0.01% | 3419 |
|
|
2017
Q2 | $40K | Sell |
618
-280
| -31% | -$17.3K | ﹤0.01% | 3311 |
|
|
2017
Q1 | $51K | Sell |
898
-278
| -24% | -$16.6K | ﹤0.01% | 3080 |
|
|
2016
Q4 | $72K | Hold |
1,176
| – | – | ﹤0.01% | 2984 |
|
|
2016
Q3 | $82K | Hold |
1,176
| – | – | ﹤0.01% | 2877 |
|
|
2016
Q2 | $65K | Hold |
1,176
| – | – | ﹤0.01% | 2975 |
|
|
2016
Q1 | $72K | Buy |
1,176
+618
| +111% | +$36.4K | ﹤0.01% | 2919 |
|
|
2015
Q4 | $36K | Buy |
558
+218
| +64% | +$14.1K | ﹤0.01% | 3164 |
|
|
2015
Q3 | $23K | Hold |
340
| – | – | ﹤0.01% | 3207 |
|
|
2015
Q2 | $23K | Sell |
340
-300
| -47% | -$19K | ﹤0.01% | 3263 |
|
|
2015
Q1 | $36K | Hold |
640
| – | – | ﹤0.01% | 3053 |
|
|
2014
Q4 | $33K | Hold |
640
| – | – | ﹤0.01% | 3191 |
|
|
2014
Q3 | $24K | Sell |
640
-300
| -32% | -$10.8K | ﹤0.01% | 3409 |
|
|
2014
Q2 | $37K | Sell |
940
-7,110
| -88% | -$264K | ﹤0.01% | 3337 |
|
|
2014
Q1 | $303K | Buy |
8,050
+640
| +9% | +$22.4K | ﹤0.01% | 2322 |
|
|
2013
Q4 | $280K | Buy |
7,410
+50
| +0.7% | +$1.91K | ﹤0.01% | 2091 |
|
|
2013
Q3 | $319K | Hold |
7,360
| – | – | ﹤0.01% | 2018 |
|
|
2013
Q2 | $266K | Buy |
+7,360
| New | +$224K | ﹤0.01% | 2053 |
|
Other funds holding USNA
Bank of Montreal's USNA Position: Q3 2022 in Review
Bank of Montreal sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 3,414 shares — an estimated $255 sold.
Bank of Montreal first reported a position in USNA in Q2 2013 and held it in 37 quarters. The position peaked at $619K in Q3 2018. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.
- Bank of Montreal reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
- Bank of Montreal sold 3,414 Usana Health Sciences shares in Q3 2022, an estimated $255.
- Bank of Montreal first reported a position in Usana Health Sciences in Q2 2013 and held it in 37 quarters.
- Bank of Montreal's Usana Health Sciences position peaked at $619K in Q3 2018.
- 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.
Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.